|
Volumn 26, Issue 9, 2003, Pages 548-551
|
A controlled clinical study on the efficacy of recombinant human interleukin-2 in the treatment of pulmonary tuberculosis
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
RECOMBINANT PROTEIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
IMMUNOLOGY;
LUNG TUBERCULOSIS;
MICROBIOLOGY;
MIDDLE AGED;
NATURAL KILLER CELL;
RANDOMIZED CONTROLLED TRIAL;
SPUTUM;
ADOLESCENT;
ADULT;
AGED;
HUMANS;
INTERLEUKIN-2;
KILLER CELLS, NATURAL;
MIDDLE AGED;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT PROTEINS;
SPUTUM;
TUBERCULOSIS, PULMONARY;
|
EID: 1542751424
PISSN: 10010939
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|